BlackRock Fund Advisors - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$2,612,000
-35.3%
446,443
-27.3%
0.00%
-100.0%
Q3 2016$4,038,000
-23.1%
613,698
+8.4%
0.00%0.0%
Q2 2016$5,254,000
+36.4%
566,112
+58.5%
0.00%0.0%
Q1 2016$3,853,000
-20.0%
357,058
+6.2%
0.00%0.0%
Q4 2015$4,815,000
+58.4%
336,227
+132.3%
0.00%0.0%
Q3 2015$3,040,000144,7140.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,962,657$3,100,0002.37%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 100,000$62,0000.02%
SlateStone Wealth, LLC 62,000$39,0000.01%
Allred Capital Management, LLC 24,995$15,0000.01%
Bridge Advisory, LLC 23,564$15,0000.01%
Livingston Group Asset Management CO (operating as Southport Capital Management) 24,000$15,0000.01%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$201,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 229,500$143,0000.00%
Virtu Financial LLC 41,401$26,0000.00%
TSFG, LLC 200$1,0000.00%
View complete list of NEOS THERAPEUTICS INC shareholders